Contract with Customer, Liability, Current of Applied Therapeutics, Inc. from 31 Dec 2023 to 30 Sep 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
- Summary
-
Applied Therapeutics, Inc. quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
- Applied Therapeutics, Inc. Contract with Customer, Liability, Current for the quarter ending 30 Sep 2025 was $212,000, unchanged year-over-year.
- Source SEC data
- View on sec.gov
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)
Applied Therapeutics, Inc. Quarterly Contract with Customer, Liability, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | $212,000 | $0 | 0% | 30 Sep 2025 | 10-Q | 13 Nov 2025 | 2025 | Q3 |
| Q2 2025 | $212,000 | -$121,000 | -36% | 30 Jun 2025 | 10-Q | 13 Aug 2025 | 2025 | Q2 |
| Q1 2025 | $212,000 | -$265,000 | -56% | 31 Mar 2025 | 10-Q | 14 May 2025 | 2025 | Q1 |
| Q4 2024 | $212,000 | -$455,000 | -68% | 31 Dec 2024 | 10-Q | 13 Nov 2025 | 2025 | Q3 |
| Q3 2024 | $212,000 | 30 Sep 2024 | 10-Q | 07 Nov 2024 | 2024 | Q3 | ||
| Q2 2024 | $333,000 | 30 Jun 2024 | 10-Q | 07 Aug 2024 | 2024 | Q2 | ||
| Q1 2024 | $477,000 | 31 Mar 2024 | 10-Q | 09 May 2024 | 2024 | Q1 | ||
| Q4 2023 | $667,000 | 31 Dec 2023 | 10-K | 15 Apr 2025 | 2024 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.